Targeted colonic release formulations of mesalazine – A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis

F. Varum, H. Thorne, R. Bravo, D. Gilgen, C. Hartig, G.P. Nicolas, D. Wild, E. Liakoni, M. Haschke

Source record

Source: Crossref

Published: Sep 1, 2022

DOI: 10.1016/j.ijpharm.2022.122055

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.